Drug Res (Stuttg) 2014; 64(10): 553-558
DOI: 10.1055/s-0033-1363976
Original Article
© Georg Thieme Verlag KG Stuttgart · New York

Synthesis and Antitubercular Activity of Novel 3,5-diaryl-4,5-dihydro-1H-pyrazole Derivatives

S. G. Alegaon
1   Department of Pharmaceutical Chemistry, KLE University’s College of Pharmacy, Belgaum, Karnataka, India
,
K. R. Alagawadi
1   Department of Pharmaceutical Chemistry, KLE University’s College of Pharmacy, Belgaum, Karnataka, India
,
D. H. Dadwe
1   Department of Pharmaceutical Chemistry, KLE University’s College of Pharmacy, Belgaum, Karnataka, India
› Author Affiliations
Further Information

Publication History

received 17 November 2013

accepted 16 December 2013

Publication Date:
20 January 2014 (online)

Preview

Abstract

Novel 3,5-diaryl-4,5-dihydro-1H-pyrazole derivatives were efficiently synthesized and evaluated for their in vitro antitubercular activity against Mycobacterium tuberculosis H37Rv (MTB). The chemical structures of the compound were elucidated by elemental analysis, FTIR, 1H NMR, and mass spectral data. Most of the title compounds have exhibited significant antitubercular activity. Compounds 4g, 4h, 4l, 4n and 4o showed pronounced antitubercular activity comparable to the reference isoniazid, whereas, compounds 4a, 4c, 4j, 4k, and 4p displayed good antitubercular activity. 5-(4-chlorophenyl)-4,5-dihydro-3-p-tolylpyrazol-1-yl-(6-methylimidazo[2,1-b]thiazol-5-yl)methanone (4g) was found to be the most promising compound with MIC values of 0.39 µg/ml.